Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01 (month) in 3mo
ESTIMATED |
READOUT
An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction
Phase 3 · Ocular Hyperemia |
Alcon Research | Apraclonidine Ophthalmic Solution, 0.125 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-17
Sponsor-projected date — can change
|
| 2027-02 (month) in 4mo
ESTIMATED |
READOUT
Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adul
Phase 3 · Ocular Hyperemia |
Alcon Research | Apraclonidine Ophthalmic Solution, 0.125 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-17
Sponsor-projected date — can change
|